4-iodophenyl-9-methylpentadecanoic acid and Myocardial Infarction

4-iodophenyl-9-methylpentadecanoic acid has been researched along with Myocardial Infarction in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Belyanin, MV; Filimonov, VD; Il'ina, EA; Il'yushenkova, YN; Lishmanov, YB; Minin, SM; Nesterov, EA; Sazonova, SI; Skuridin, VS; Stepanova, EV; Tsibul'nikov, SV; Varlamova, NV	1
Horikoshi, M; Lee, JD; Nakano, A; Okura, K; Shimizu, H; Takahashi, N; Tsuchida, T; Ueda, T; Yonekura, Y	1
Fukuchi, K; Hasegawa, S; Ito, Y; Nishimura, T; Uehara, T; Yamaguchi, H; Yoshioka, J	1

Trials

1 trial(s) available for 4-iodophenyl-9-methylpentadecanoic acid and Myocardial Infarction

Article	Year
Reversible defect of 123I-15-(p-iodophenyl)-9-(R,S)-methylpentadecanoic acid indicates residual viability within infarct-related area. Annals of nuclear medicine, 2002, Volume: 16, Issue:3 Topics: Aged; Fatty Acids; Female; Fluorodeoxyglucose F18; Heart; Humans; Iodobenzenes; Male; Middle Aged; Myocardial Infarction; Myocardial Stunning; Myocardium; Radiography; Radionuclide Imaging; Radiopharmaceuticals; Reference Values	2002

Article

Year

Reversible defect of 123I-15-(p-iodophenyl)-9-(R,S)-methylpentadecanoic acid indicates residual viability within infarct-related area.

Annals of nuclear medicine, 2002, Volume: 16, Issue:3

Topics: Aged; Fatty Acids; Female; Fluorodeoxyglucose F18; Heart; Humans; Iodobenzenes; Male; Middle Aged; Myocardial Infarction; Myocardial Stunning; Myocardium; Radiography; Radionuclide Imaging; Radiopharmaceuticals; Reference Values

2002

Other Studies

2 other study(ies) available for 4-iodophenyl-9-methylpentadecanoic acid and Myocardial Infarction

Article	Year
Experimental Study of a Radiopharmaceutical Agent Based on Modified Fatty Acid Labeled with Technetium-99m. Bulletin of experimental biology and medicine, 2017, Volume: 162, Issue:6 Topics: Animals; Coronary Occlusion; Fatty Acids; Heart; Iodine Radioisotopes; Iodobenzenes; Kidney; Liver; Male; Myocardial Infarction; Myocardial Perfusion Imaging; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Wistar; Staining and Labeling; Technetium; Tissue Distribution	2017
Detection of coronary artery disease by iodine-123-labeled iodophenyl-9-methyl pentadecanoic acid SPECT: comparison with thallium-201 and iodine-123 BMIPP SPECT. Annals of nuclear medicine, 2000, Volume: 14, Issue:1 Topics: Angina Pectoris; Coronary Disease; Exercise Test; Fatty Acids; Humans; Iodine Radioisotopes; Iodobenzenes; Middle Aged; Myocardial Infarction; Myocardium; Predictive Value of Tests; Sensitivity and Specificity; Thallium Radioisotopes; Tissue Distribution; Tomography, Emission-Computed, Single-Photon	2000

Article

Year

Experimental Study of a Radiopharmaceutical Agent Based on Modified Fatty Acid Labeled with Technetium-99m.

Bulletin of experimental biology and medicine, 2017, Volume: 162, Issue:6

Topics: Animals; Coronary Occlusion; Fatty Acids; Heart; Iodine Radioisotopes; Iodobenzenes; Kidney; Liver; Male; Myocardial Infarction; Myocardial Perfusion Imaging; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Wistar; Staining and Labeling; Technetium; Tissue Distribution

2017

Detection of coronary artery disease by iodine-123-labeled iodophenyl-9-methyl pentadecanoic acid SPECT: comparison with thallium-201 and iodine-123 BMIPP SPECT.

Annals of nuclear medicine, 2000, Volume: 14, Issue:1

Topics: Angina Pectoris; Coronary Disease; Exercise Test; Fatty Acids; Humans; Iodine Radioisotopes; Iodobenzenes; Middle Aged; Myocardial Infarction; Myocardium; Predictive Value of Tests; Sensitivity and Specificity; Thallium Radioisotopes; Tissue Distribution; Tomography, Emission-Computed, Single-Photon

2000